Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoblastic Lymphoma in Complete Remission”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Study completedNCT02458014
What this trial is testing

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

Who this might be right for
Adult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more
M.D. Anderson Cancer Center 36
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Post-approval studies (Phase 4)Ended earlyNCT04506086
What this trial is testing

Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B-precursor Acute Lymphoblastic Leukemia
Amgen 10
Testing effectiveness (Phase 2)Looking for participantsNCT06718244
What this trial is testing

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1

Who this might be right for
Acute Lymphoblastic Leukemia
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01266083
What this trial is testing

WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Sellas Life Sciences Group 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982
What this trial is testing

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more
M.D. Anderson Cancer Center 88
Large-scale testing (Phase 3)UnknownNCT02070523
What this trial is testing

Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia:

Who this might be right for
Acute Lymphoblastic Leukemia
Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. 200
Early research (Phase 1)Looking for participantsNCT05535855
What this trial is testing

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1

Who this might be right for
Acute Lymphoid LeukemiaAcute Lymphoblastic Leukemia
University of Colorado, Denver 29
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Large-scale testing (Phase 3)Looking for participantsNCT04314219
What this trial is testing

Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) in Complete RemissionAcute Myeloid Leukemia (AML) in Remission
King Faisal Specialist Hospital & Research Center 264
Not applicableStudy completedNCT02303522
What this trial is testing

Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Amgen 207
Testing effectiveness (Phase 2)Ended earlyNCT01028716
What this trial is testing

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Biphenotypic LeukemiaAcute Erythroid Leukemia in RemissionAcute Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT00031655
What this trial is testing

Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionRecurrent Adult Acute Lymphoblastic Leukemia+1 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 30
Testing effectiveness (Phase 2)Study completedNCT00002665
What this trial is testing

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

Who this might be right for
LeukemiaNeutropeniaThrombocytopenia
SWOG Cancer Research Network 50
Not applicableEnded earlyNCT02428517
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Asan Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT02605460
What this trial is testing

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid Leukemia
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 20
Testing effectiveness (Phase 2)Study completedNCT00027547
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01363128
What this trial is testing

Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete RemissionBurkitt Leukemia+4 more
M.D. Anderson Cancer Center 72
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Early research (Phase 1)Study completedNCT02446964
What this trial is testing

Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in Complete RemissionAcute Myeloid Leukemia in RemissionPreviously Treated Myelodysplastic Syndrome+5 more
City of Hope Medical Center 31
Load More Results